HKPMDC
 All     Test   
 
News & Event
 
New Test Available: FOLR1 Immunohistochemistry

Date: 2024-11-06
 

 
HKMPDC Launches New Actionable Cancer NGS Panels

Date: 0000-00-00
 

 
HKMPDC SARS-CoV-2 (COVID-19) Real-time RT-PCR Assay received CE-IVD marking

Date: 0000-00-00
 

 
$title
HKMPDC is offering COVID-19 (2019-nCoV) real-time RT-PCR test using CE-IVD approved assay.

Date: 0000-00-00
 

 
HKMPDC to provide PIK3CA hotspot mutation test for the first FDA approved treatment Piqray (alpelisib) for patient with PIK3CA mutation in HR+/HER2 advanced breast cancer using either tissue or blood sample.

Date: 0000-00-00
 

 
The First US FDA Approved Non-invasive (BLOOD) EGFR Mutation Test for Lung Cancer Targeted Therapy Using Liquid Biopsy

Date: 0000-00-00
 

 
HKMPDC The First HOKLAS ISO 15189:2012 Accredited Laboratory for Molecular Oncology Testing.

Date: 0000-00-00
 

 
Scientific Seminar on Molecular Profiling in Cancer Medicine

Date: 2015-12-21
 

 
The Hong Kong Molecular Pathology Diagnostic Centre (HKMPDC) is the exclusive service provider of FoundationOne test in Hong Kong.

Date: 2015-10-27
 

 
We Have Moved to a New Office!

Date: 2015-01-24
 

 
Non-Invasive Prenatal Testing (NIPT) for Down syndrome

Date: 2013-12-10
 

 
The Hong Kong Molecular Pathology Diagnostic Centre is the official service provide for Harmony Prenatal Test in Hong Kong and Macau

Date: 2013-12-03
 

 
醫療專題講座 - 從乳癌中探討癌症的遺傳及預防

Date: 2013-06-06
 

Phone: +852.2986.1213
Fax:+852.2527.7028
E-mail:contact@hk-mpdc.com
27/F., Strand 50, No.50 Bonham Strand, Sheung Wan, Hong Kong
Opening Hours
Mondays to Fridays: 09:00-18:00
Saturdays: 09:00-16:00
Sundays and Public Holidays: Closed

For specimen pickup arrangements, please phone +852.2986.1213


Shipping & Billing Information

HOKLAS accreditation scope